P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971116.17929.06 |
| _version_ | 1797280853173207040 |
|---|---|
| author | Justin M. Watts Anthony M. Hunter Alessandra Iurlo Blanca Xicoy Francesca Palandri Brandi Reeves Alessandro Vannucchi Prithviraj Bose Rosa Ayala Diaz Anna B. Halpern Xuejun Chen Francis Seguy Feng Zhou Fred Zheng Pankit Vachhani |
| author_facet | Justin M. Watts Anthony M. Hunter Alessandra Iurlo Blanca Xicoy Francesca Palandri Brandi Reeves Alessandro Vannucchi Prithviraj Bose Rosa Ayala Diaz Anna B. Halpern Xuejun Chen Francis Seguy Feng Zhou Fred Zheng Pankit Vachhani |
| author_sort | Justin M. Watts |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:47:13Z |
| format | Article |
| id | doaj.art-701a01ff7dea43e6b160800d08dc06e1 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:47:13Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-701a01ff7dea43e6b160800d08dc06e12024-03-03T06:25:13ZengWileyHemaSphere2572-92412023-08-017e179290610.1097/01.HS9.0000971116.17929.06202308003-00953P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDYJustin M. Watts0Anthony M. Hunter1Alessandra Iurlo2Blanca Xicoy3Francesca Palandri4Brandi Reeves5Alessandro Vannucchi6Prithviraj Bose7Rosa Ayala Diaz8Anna B. Halpern9Xuejun Chen10Francis Seguy11Feng Zhou12Fred Zheng13Pankit Vachhani141 Sylvester Cancer Center, University of Miami, Miami, United States2 Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States3 Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy4 Hospital Germans Trias i Pujol, Institut Català d’Oncologia, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain5 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy6 University of North Carolina School of Medicine, Chapel Hill, United States7 AOU Careggi, University of Florence, Florence, Italy8 The University of Texas MD Anderson Cancer Center, Houston, United States9 Hospital Universitario 12 de Octubre, Madrid, Spain10 University of Washington, Seattle, United States12 Incyte Corporation, Wilmington, United States13 Incyte Biosciences International Sàrl, Morges, Switzerland12 Incyte Corporation, Wilmington, United States12 Incyte Corporation, Wilmington, United States14 O’Neal Comprehensive Cancer Center at UAB, Birmingham, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000971116.17929.06 |
| spellingShingle | Justin M. Watts Anthony M. Hunter Alessandra Iurlo Blanca Xicoy Francesca Palandri Brandi Reeves Alessandro Vannucchi Prithviraj Bose Rosa Ayala Diaz Anna B. Halpern Xuejun Chen Francis Seguy Feng Zhou Fred Zheng Pankit Vachhani P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY HemaSphere |
| title | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
| title_full | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
| title_fullStr | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
| title_full_unstemmed | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
| title_short | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
| title_sort | p1055 bromodomain and extra terminal bet inhibitor incb057643 limber 103 in patients pts with relapsed or refractory myelofibrosis r r mf and other advanced myeloid neoplasms a phase 1 study |
| url | http://journals.lww.com/10.1097/01.HS9.0000971116.17929.06 |
| work_keys_str_mv | AT justinmwatts p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT anthonymhunter p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT alessandraiurlo p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT blancaxicoy p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT francescapalandri p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT brandireeves p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT alessandrovannucchi p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT prithvirajbose p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT rosaayaladiaz p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT annabhalpern p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT xuejunchen p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT francisseguy p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT fengzhou p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT fredzheng p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT pankitvachhani p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study |